Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research
May 02 2024 - 9:30AM
Business Wire
This innovative collaboration will help improve
adoption of measurement-based care and precision psychiatry to
enhance diagnostic and treatment practices
Today, Osmind, the leading psychiatric treatment and research
platform, announced an innovative collaboration with the American
Psychiatric Association (APA) to improve the adoption of
measurement-based care (MBC) and precision treatment in psychiatry.
This collaboration between Osmind and APA’s PsychPRO registry
intends to broaden access to personalized care, improve patient
outcomes, generate robust real-world evidence (RWE) and accelerate
psychiatry’s evolution to precision medicine. PsychPRO registry is
a clinical data registry that enables the collection and analysis
of clinical data to advance quality improvement efforts and
accelerate research for the psychiatric community.
"At Osmind, we emphasize the importance of clinicians
participating in evidence-generating medicine to help shape the
future of mental health care, especially as the psychiatric field
begins to embrace new treatments and precision psychiatry,” said
Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians
in private practice juggle many competing demands so it is crucial
we make participation both easy and worthwhile to them."
Osmind is integrating a number of APA’s diagnostic and outcomes
measures of interest, including the DSM-5-TR Self-Rated Level 1
Cross-Cutting Symptom Measure developed by APA researchers, into
its electronic health record (EHR) software. The first measure of
interest is now available to Osmind clinicians and is part of a
library of 40+ measures already in its EHR. Osmind will also help
promote adoption of the new APA measures through education,
automation, and engagement directly in the EHR at the point of
care.
Osmind and APA will additionally explore a seamless integration
between the Osmind EHR and PsychPRO so that clinicians using the
Osmind EHR can participate effortlessly in the PsychPRO registry.
PsychPRO participation supports the standardization of high-quality
care and benefits clinicians. Key benefits for clinicians include
the ability to better understand how the care they deliver impacts
their patient outcomes, and how their patient outcomes compare to
their peers across the country in all types of care settings.
Following the successful prospective data capture phase, the
collaboration plans to also consider joint research initiatives.
Data and feedback collected by Osmind and PsychPRO would be used to
analyze outcomes, validate the effectiveness of the measures,
enhance clinical practices and guide ongoing research in precision
psychiatry.
"PsychPRO is the tool healthcare organizations need to guide
their efforts to deliver quality mental health care and improve
patient outcomes," said Nitin Gogtay, MD, APA Chief of Research and
Deputy Medical Director. "Our collaboration with Osmind will allow
us to strengthen PsychPRO today, and long-term offers promise to
broaden the scope of our impact on psychiatry and on the patients
we serve."
Osmind’s modern and easy-to-use EHR serves independent
psychiatric practices across the country, helping them treat their
patients with the highest quality care. Through this collaboration,
Osmind is enabling independent practices to contribute to the
evolution of the field and elevate their own evidence-based
practices.
About Osmind
Osmind is a San Francisco–based public benefit corporation led
by scientists, technologists, and psychiatrists to advance new
evidence-generating medicine that helps people living with moderate
to severe mental health conditions. For more information, please
visit www.osmind.org.
About the American Psychiatric Association
The American Psychiatric Association, founded in 1844, is the
oldest medical association in the country. The APA is also the
largest psychiatric association in the world with more than 38,900
physician members specializing in the diagnosis, treatment,
prevention, and research of mental illnesses. APA’s vision is to
ensure access to quality psychiatric diagnosis and treatment. For
more information, please visit www.psychiatry.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502892383/en/
Sabas Rodriguez press@osmind.org